Home > Journals > Esperienze Dermatologiche > Past Issues > Esperienze Dermatologiche 2013 September;15(3) > Esperienze Dermatologiche 2013 September;15(3):101-6





A Journal on Dermatology

Journal of Istituto Dermatologico San Gallicano
Official Journal of the Associazione Dermatologi Ospedalieri Italiani - A.D.O.I.
Indexed/Abstracted in: EMBASE, Scopus



Esperienze Dermatologiche 2013 September;15(3):101-6

language: Italian

Non-melanoma skin cancers: which follow-up?

Patrizi A., Venturi M., Dika E.

Unità di Dermatologia, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Policlinico Universitario S. Orsola-Malpighi, Università di Bologna, Bologna, Italia


Non-melanoma skin cancers (NMSC) are a frequent group of tumors with a multifactorial etiology and with an incidence meaningfully increased. The epithelial forms, particularly the basocellular carcinoma (BCC) and the squamocellular carcinoma (SCC), represent in absolute the most frequent neoplasms in the Caucasian race. The rationale of follow-up for patients with NMSC should be based on the risk of three distinct events: tumor recurrence, metastasis, and subsequent development of new skin tumors. To the date, there is a significant variability among the follow-up programs proposed in the recommendations of various national, European and extra-European organizations. For the BCC, the non-uniqueness of behavior is demonstrated by studies that advocate a plan of follow-up, and others which do not detect the need, particularly in the case of completely removed BCC. With regard to the SCC, studies have been conducted about the optimal strategy for follow-up, and there are no data that define the profile of patients who can benefit from them.

top of page

Publication History

Cite this article as

Corresponding author e-mail